These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 7010289)

  • 1. Effect of indomethacin in a patient with Bartter's syndrome: evidence against a primary role of prostaglandin in this disorder.
    Etzioni A; Chaimovitz C; Levi Y; Benderli A; Better OS
    Pediatr Res; 1980 Dec; 14(12):1395-7. PubMed ID: 7010289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Bartter's syndrome: Recurrence in the course of a treatment inhibiting prostaglandin synthesis].
    Favre L; Glasson P; Flory ED; Dray F; Vallotton MB
    Schweiz Med Wochenschr; 1979 Feb; 109(5):142-7. PubMed ID: 441720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Responses to antiotensin II antagonist before and after treatment with indomethacin in Bartter's syndrome.
    Sasaki H; Okumura M; Asano T; Arakawa K; Kawasaki T
    Br Med J; 1977 Oct; 2(6093):995-6. PubMed ID: 922403
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of Sar1-ala8-angiotensin II on blood pressure and renin in Bartter's syndrome, before and after treatment with prostaglandin synthetase inhibitors.
    Rudin A; Aurell M; Hansson L; Westberg G
    Scand J Clin Lab Invest; 1979 Oct; 39(6):543-50. PubMed ID: 119300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversal of altered vascular responsiveness in Bartter's syndrome by indomethacin treatment.
    Shimoyama R
    J Clin Endocrinol Metab; 1980 Oct; 51(4):908-11. PubMed ID: 6999001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of Bartter's syndrome with indomethacin.
    Garin EH; Fennell RS; Iravani A; Richard GA
    Am J Dis Child; 1980 Mar; 134(3):258-61. PubMed ID: 6767392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of indomethacin upon the renin--angiotensin system in patients with Bartter's syndrome.
    Vierhapper H; Waldhäusl W
    Eur J Clin Invest; 1980 Apr; 10(2 Pt 1):119-24. PubMed ID: 6780358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A clinical study of pathophysiological feature of "Bartter's syndrome" (author's transl)].
    Sasaki H
    Fukuoka Igaku Zasshi; 1979 Oct; 70(10):537-84. PubMed ID: 520995
    [No Abstract]   [Full Text] [Related]  

  • 9. Role of prostaglandins in the pathogenesis of Bartter's syndrome.
    Fichman MP; Telfer N; Zia P; Speckart P; Golub M; Rude R
    Am J Med; 1976 May; 60(6):785-97. PubMed ID: 798488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Value and limitations of indomethacin in the treatment of Bartter's syndrome].
    Dequiedt P; Lefebvre J; Raviart B; Vanhille P; Lepoutre E; Lelièvre G; Tacquet A
    J Urol Nephrol (Paris); 1977 Sep; 83(9):688-93. PubMed ID: 926230
    [No Abstract]   [Full Text] [Related]  

  • 11. Bartter's syndrome results from an imbalance of vasoactive hormones.
    McGiff JC
    Ann Intern Med; 1977 Sep; 87(3):369-72. PubMed ID: 900681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of indomethacin on the vascular abnormalities of Bartter's syndrome.
    Richards CJ; Mark AL; Van Orden DE; Kaloyanides GJ
    Circulation; 1978 Sep; 58(3 Pt 1):544-9. PubMed ID: 679446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indomethacin in Bartter's syndrome: does the syndrome represent a state of hyperprostaglandinism?
    Donker AJ; de Jong PE; van Eps LW; Brentjens JR; Bakker K; Doorenbos H
    Nephron; 1977; 19(4):200-13. PubMed ID: 917167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the pathogenesis of Bartter's syndrome: report of studies in a patient with this disorder.
    Norby L; Mark AL; Kaloyanides GJ
    Clin Nephrol; 1976 Sep; 6(3):404-13. PubMed ID: 991467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bartter's syndrome: a disorder characterized by high urinary prostaglandins and a dependence of hyperreninemia on prostaglandin synthesis.
    Gill JR; Frölich JC; Bowden RE; Taylor AA; Keiser HR; Seyberth HW; Oates JA; Bartter FC
    Am J Med; 1976 Jul; 61(1):43-51. PubMed ID: 820194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostaglandin synthetase inhibitors in Bartter's syndrome. Effect on immunoreactive prostaglandin E excretion.
    Bowden RE; Gill JR; Radfar N; Taylor AA; Keiser HR
    JAMA; 1978 Jan; 239(2):117-21. PubMed ID: 412983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bartter's syndrome--observations on the pathophysiology.
    Solomon LR; Bobinski H; Astley P; Goldby FS; Mallick NP
    Q J Med; 1982; 51(203):251-70. PubMed ID: 7146310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bartter's syndrome. Failure of aspirin and success of indomethacin].
    Jáuregui WO; Di Fonzo P; Marchissio ML; Roehr E; Hauger-Klevene JH
    Medicina (B Aires); 1979; 39(4):447-56. PubMed ID: 397398
    [No Abstract]   [Full Text] [Related]  

  • 19. Bartter's syndrome presenting with features resembling renal tubular acidosis. Improvement of renal tubular defects by indomethacin.
    Rodriguez-Soriano J; Vallo A; Oliveros R
    Helv Paediatr Acta; 1978 Jun; 33(2):141-51. PubMed ID: 659258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atrial natriuretic peptide levels during angiotensin infusion and indomethacin administration are consistent with angiotensin-mediated regulation in man.
    Klemm SA; Tunny TJ; Gordon RD
    J Hypertens Suppl; 1987 Dec; 5(5):S75-8. PubMed ID: 2965235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.